Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 2, 2012, Pages

  Herczenik, Eszter ^a   Van Haren, Simon D ^a   Wroblewska, Aleksandra ^a   Kaijen, Paul ^a   Van Den Biggelaar, Maartje ^a   Meijer, Alexander B ^a   Martinez Pomares, Luisa ^b   Ten Brinke, Anja ^a   Voorberg, Jan ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

antibody formation; coagulation factor VIII; dendritic cells; endocytosis; Hemophilia

Indexed keywords

ALPHA 2 MACROGLOBULIN; BLOOD CLOTTING FACTOR 8; IMMUNOGLOBULIN G1; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MANNAN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KM33; MONOCLONAL ANTIBODY VK34; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING COMPETITION; BINDING SITE; BONE MARROW CELL; CELL SURFACE; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; GENE SILENCING; HEMOPHILIA A; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; KNOCKOUT MOUSE; LIGAND BINDING; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RECEPTOR BINDING;

EID: 84856486915     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.08.029     Document Type: Article

References (57)

1. P.M. Mannucci, and E.G. Tuddenham The hemophilias - from royal genes to gene therapy N Engl J Med 344 2001 1773 1779
2. C.L. Kempton, and G.C. White II How we treat a hemophilia A patient with a factor VIII inhibitor Blood 113 2009 11 17
3. K. Fijnvandraat, W.S. Bril, and J. Voorberg Immunobiology of inhibitor development in hemophilia A Semin Thromb Hemost 29 2003 61 68
4. P. Lollar Pathogenic antibodies to coagulation factors, Part one: factor VIII and factor IX J Thromb Haemost 2 2004 1082 1095
5. D. Dimichele Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach J Thromb Haemost 5 2007 143 150
6. + T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects Thromb Haemost 84 2000 643 652
7. P.M. van Helden, H.M. van den Berg, and S.C. Gouw IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A Br J Haematol 142 2008 644 652
8. M.G. Jacquemin, B.G. Desqueper, and A. Benhida Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor Blood 92 1998 496 506
9. E.N. van den Brink, E.A. Turenhout, C.M. Bank, K. Fijnvandraat, M. Peters, and J. Voorberg Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain Blood 96 2000 540 545
10. K. Rajewsky Clonal selection and learning in the antibody system Nature 381 1996 751 758
11. S. Lacroix-Desmazes, A.M. Navarrete, S. Andre, J. Bayry, S.V. Kaveri, and S. Dasgupta Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A Blood 112 2008 240 249
12. K. Shortman, and Y.J. Liu Mouse and human dendritic cell subtypes Nat Rev Immunol 2 2002 151 161
13. A. Navarrete, S. Dasgupta, and S. Delignat Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A J Thromb Haemost 7 2009 1816 1823
14. K. Pfistershammer, J. Stockl, J. Siekmann, P.L. Turecek, H.P. Schwarz, and B.M. Reipert Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells Thromb Haemost 96 2006 309 316
15. M. Qadura, M. Othman, and B. Waters Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells J Thromb Haemost 6 2008 2095 2104
16. + T lymphocytes Proc Natl Acad Sci U S A 104 2007 8965 8970
17. K.F. Medzihradszky, M.J. Besman, and A.L. Burlingame Structural characterization of site-specific N-glycosylation of recombinant human factor VIII by reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry Anal Chem 69 1997 3986 3994
18. J.J. Garcia-Vallejo, and Y. van Kooyk Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis Immunol Rev 230 2009 22 37
19. N. Bovenschen, J. Herz, and J.M. Grimbergen Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency Blood 101 2003 3933 3939
20. P.J. Lenting, J.G. Neels, and B.M. van den Berg The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein J Biol Chem 274 1999 23734 23739
21. E.L. Saenko, A.V. Yakhyaev, I. Mikhailenko, D.K. Strickland, and A.G. Sarafanov Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism J Biol Chem 274 1999 37685 37692
22. E.N. van den Brink, E.A. Turenhout, and N. Bovenschen Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VIII Blood 97 2001 966 972
23. N. Bovenschen, R.C. Boertjes, and G. van Stempvoort Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII J Biol Chem 278 2003 9370 9377
24. N. Bovenschen, G. van Stempvoort, J. Voorberg, K. Mertens, and A.B. Meijer Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain J Thromb Haemost 4 2006 1487 1493
25. S.D. van Haren, E. Herczenik, A. Ten Brinke, K. Mertens, J. Voorberg, and A.B. Meijer HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII Mol Cell Proteomics 10 2011 M110.002246
26. E.N. van den Brink, W.S. Bril, and E.A. Turenhout Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII Blood 99 2002 2828 2834
27. A. Amini-Nekoo, T.S. Futers, M. Moia, P.M. Mannucci, P.J. Grant, and R.A. Ariens Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis Br J Haematol 113 2001 537 543
28. H. Meems, A.B. Meijer, D.B. Cullinan, K. Mertens, and G.E. Gilbert Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity Blood 114 2009 3938 3946
29. L. Martinez-Pomares, D. Wienke, and R. Stillion Carbohydrate-independent recognition of collagens by the macrophage mannose receptor Eur J Immunol 36 2006 1074 1082
30. I. Mikhailenko, F.D. Battey, and M. Migliorini Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions J Biol Chem 276 2001 39484 39491
31. M. Kessler, D. Goldsmith, and H. Schellekens Immunogenicity of biopharmaceuticals Nephrol Dial Transplant 21 2006 v9 v12
32. S.C. Gouw, J.G. van der Bom, and H. Marijke van den Berg Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study Blood 109 2007 4648 4654
33. A. Pavlova, H. Brondke, J. Musebeck, H. Pollmann, A. Srivastava, and J. Oldenburg Molecular mechanisms underlying hemophilia A phenotype in seven females J Thromb Haemost 7 2009 976 982
34. +-dependent mechanism and by shifting cytokine production to favor a Th1 response Blood 113 2009 193 203
35. R.E. Mebius, and G. Kraal Structure and function of the spleen Nat Rev Immunol 5 2005 606 616
36. N. Bovenschen, K. Mertens, L. Hu, L.M. Havekes, and B.J. van Vlijmen LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo Blood 106 2005 906 912
37. A.B. Meijer, J. Rohlena, and C. van der Zwaan Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII Biochim Biophys Acta 1774 2007 714 722
38. S. Dasgupta, A.M. Navarrete, and S. Andre Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation Haematologica 93 2008 83 89
39. S. Burgdorf, and C. Kurts Endocytosis mechanisms and the cell biology of antigen presentation Curr Opin Immunol 20 2008 89 95
40. P. Stahl, P.H. Schlesinger, E. Sigardson, J.S. Rodman, and Y.C. Lee Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling Cell 19 1980 207 215
41. H.J. Brinkman, K. Mertens, and J.A. van Mourik Phospholipid-binding domain of factor VIII is involved in endothelial cell-mediated activation of factor X by factor IXa Arterioscler Thromb Vasc Biol 22 2002 511 516
42. P.M. van Helden, H.M. van den Berg, and S.C. Gouw IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A Br J Haematol 142 2008 644 652
43. M. van den Biggelaar, R. Bierings, G. Storm, J. Voorberg, and K. Mertens Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies J Thromb Haemost 5 2007 2235 2242
44. S.A. Linehan, L. Martinez-Pomares, R.P. da Silva, and S. Gordon Endogenous ligands of carbohydrate recognition domains of the mannose receptor in murine macrophages, endothelial cells and secretory cells: potential relevance to inflammation and immunity Eur J Immunol 31 2001 1857 1866
45. L. Martinez-Pomares, D. Wienke, and R. Stillion Carbohydrate-independent recognition of collagens by the macrophage mannose receptor Eur J Immunol 36 2006 1074 1082
46. J.G. Neels, B.M. van Den Berg, A. Lookene, G. Olivecrona, H. Pannekoek, and A.J. van Zonneveld The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties J Biol Chem 274 1999 31305 31311
47. A.B. Meijer, J. Rohlena, and C. van der Zwaan Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha2-macroglobulin, factor IXa and factor VIII Biochim Biophys Acta 1774 2007 714 722
48. N. Bovenschen, R.C. Boertjes, and G. van Stempvoort Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII J Biol Chem 278 2003 9370 9377
49. E.N. van den Brink, W.S. Bril, and E.A. Turenhout Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII Blood 99 2002 2828 2834
50. H. Meems, A.B. Meijer, D.B. Cullinan, K. Mertens, and G.E. Gilbert Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity Blood 114 2009 3938 3946
51. L. Bi, A.M. Lawler, S.E. Antonarakis, K.A. High, J.D. Gearhart, and H.H. Kazazian Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A Nat Genet 10 1995 119 121
52. L. Bi, R. Sarkar, and T. Naas Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies Blood 88 1996 3446 3450
53. E.M. Muchitsch, P.L. Turecek, and K. Zimmermann Phenotypic expression of murine hemophilia Thromb Haemost 82 1999 1371 1373
54. B.M. Reipert, R.U. Ahmad, P.L. Turecek, and H.P. Schwarz Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A Thromb Haemost 84 2000 826 832
55. J. Qian, M. Collins, A.H. Sharpe, and L.W. Hoyer Prevention and treatment of factor VIII inhibitors in murine hemophilia A Blood 95 2000 1324 1329
56. A. Ten Brinke, M.L. Karsten, M.C. Dieker, J.J. Zwaginga, and S.M. van Ham The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization Vaccine 25 2007 7145 7152
57. J. Ronnmark, M. Hansson, and T. Nguyen Construction and characterization of affibody-Fc chimeras produced in Escherichia coli J Immunol Methods 261 2002 199 211